Showing results (161-170 of 180) with videos related to
Sort By:
Pageof 18
The Journal of Arthroplasty|May 16, 2019
Intraoperative Ketamine in Total Knee Arthroplasty Does Not Decrease Pain and Narcotic Consumption: A Prospective Randomized Controlled TrialTimothy L Tan, Andrew S Longenecker, Janet H Rhee, et al.The Journal of Arthroplasty|March 16, 2023
Robotic-Assisted Total Knee Arthroplasty: What are Patients' Perspectives, Understanding and Expectations?Mohammad S Abdelaal, Bright M Wiafe, Irfan A Khan, et al.Scientific Data|June 21, 2022
The NEON Daily Isotopic Composition of Environmental Exchanges DatasetCatherine E Finkenbiner, Bonan Li, Lindsey Spencer, et al.Clinical EEG and Neuroscience|November 29, 2021
Olfactory Function and Diffusion Tensor Imaging as Markers of Mild Cognitive Impairment in Early Stages of Parkinson's DiseaseSophie A Stewart, Laura Pimer, John D Fisk, et al.Clinical Parkinsonism & Related Disorders|January 12, 2023
Aberrant corticospinal tract characteristics in prodromal PD: A diffusion tensor imaging studyLaura J Pimer, Ronald A Leslie, Gosia Phillips, et al.Journal of Neurology|June 28, 2017
Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigraN Joshi, T M Rolheiser, J D Fisk, et al.BMJ Open|July 18, 2023
Pan-Canadian study of psychiatric care (PCPC): protocol for a mixed-methods studyDavid Rudoler, M Ruth Lavergne, Emily Gard Marshall, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 28, 2025
Regional Variation in Supply and Use of Psychiatric Services in 3 Canadian Provinces: Variation régionale de l'offre de services psychiatriques et de leur utilisation dans trois provinces canadiennesDavid Rudoler, Ridhwana Kaoser, M Ruth Lavergne, et al.Neuron|August 5, 1999
Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balanceS Hahm, T M Mizuno, T J Wu, et al.Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.Pageof 18